Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Science6 min read

How GLP-1 Medications Actually Work for Weight Loss

A clear breakdown of how semaglutide and tirzepatide help with weight loss - the science, the process, and what happens in your body.

Updated September 15, 2026

Medically reviewed on

How we review

What Are GLP-1 Medications?

Woman holding a GLP-1 weight-loss injection pen at a kitchen counter with a healthy salad, water, a measuring tape and dumbbells
GLP-1 receptor agonists are a class of prescription medications originally developed for type 2 diabetes. They mimic a natural hormone called glucagon-like peptide-1, which your gut produces after eating. Medications like semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (used in Mounjaro and Zepbound) have shown remarkable results for weight management in clinical trials, leading to FDA approval specifically for weight loss.

Our top 2 picks

Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review

How They Reduce Appetite

GLP-1 medications work primarily by targeting receptors in the brain that regulate hunger and satiety. When you take these medications, they slow gastric emptying - meaning food stays in your stomach longer - and signal to your brain that you are full.

Many patients describe it as the volume being turned down on food noise: the constant background chatter of cravings and hunger that can make weight management so difficult. This isn't willpower - it's biochemistry.

The Role of Insulin and Blood Sugar

Beyond appetite suppression, GLP-1 medications help regulate blood sugar by stimulating insulin release when glucose levels are high and reducing glucagon secretion. This dual action helps prevent the blood sugar spikes and crashes that often trigger cravings and overeating. For patients with insulin resistance - a common factor in weight gain - this mechanism can be particularly beneficial.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

Tirzepatide: The Dual-Action Approach

Tirzepatide takes things a step further by targeting two receptors: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual-agonist approach has shown even greater weight loss results in clinical trials, with some participants losing over 20% of their body weight.

For a detailed comparison, see our guide on tirzepatide vs semaglutide. The GIP receptor activation provides additional metabolic benefits that complement the GLP-1 pathway.

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

What to Realistically Expect

Clinical trials show average weight loss of 15-20% of body weight with semaglutide and up to 22% with tirzepatide over 68-72 weeks. However, results vary significantly between individuals.

Most patients begin noticing appetite changes within the first two weeks, with meaningful weight loss becoming visible around weeks 4-8. For a week-by-week breakdown, read our guide on what to expect your first month on medication.

The medications are typically administered as once-weekly injections, with doses gradually increased over several months to minimize side effects.

Common Side Effects

The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These are usually most pronounced during dose increases and tend to improve over time.

Starting at a low dose and gradually titrating up helps most patients manage these effects. For a full breakdown, see our semaglutide side effects guide.

More serious but rare side effects include pancreatitis and gallbladder problems, which is why medical supervision during treatment is important. Take our quiz to find a provider with strong clinical oversight.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)